Brexit Disrupts Cancer Trials
This is a UK news story, published by Guardian, that relates primarily to Britons news.
UK news
For more UK news, you can click here:
more UK newsBritons news
For more Britons news, you can click here:
more Britons newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
UK cancer research. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest British cancer patients news, overall European cancer research effort news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Cancer Research UKGuardian
•Health
Health
NHS cancer patients denied life-saving drugs due to Brexit costs, report finds

68% Informative
British cancer patients are being denied life-saving drugs and trials of revolutionary treatments are being derailed by the red tape and extra costs brought on by the EU .
The cost of importing new cancer drugs for Britons has nearly quadrupled as a result of post-Brexit red tape.
The extra rules and costs have had a “significant negative impact” on UK cancer research, a report warns.
Without it, patients will experience further delays to trials in future, it says.
Government has been providing extensive support for researchers to help them secure funding from the 80bn Horizon Europe programme.
Last year , the Guardian revealed how hundreds of thousands of people in the UK were being forced to wait months to begin even basic cancer treatment.
VR Score
76
Informative language
81
Neutral language
5
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links